Evidence map›Paper›PMID 40716043›Full record

ArticleBriefings in bioinformatics2025

Deep graph convolutional network-based multi-omics integration for cancer driver gene identification.

Yingzhuo Wu, Jialuo Xu, Junming Li, Jia Gu, Xuequn Shang, Xingyi Li

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Disentangling Heterogeneous Molecular Networks for Multi-Omics-Driven Cancer Driver Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingzhuo WuSchool of Computer Science, Northwestern Polytechnical University, Xi'an, 710072 Shaanxi, China.
Jialuo XuSchool of Computer Science, Northwestern Polytechnical University, Xi'an, 710072 Shaanxi, China.
Junming LiSchool of Software, Northwestern Polytechnical University, Xi'an, 710072 Shaanxi, China.
Jia GuFaculty of Data Science, City University of Macau, Macau, 999078 Macau, China.
Xuequn ShangSchool of Computer Science, Northwestern Polytechnical University, Xi'an, 710072 Shaanxi, China.
Xingyi LiSchool of Computer Science, Northwestern Polytechnical University, Xi'an, 710072 Shaanxi, China.

Funding

Guangdong Basic and Applied Basic Research Foundation 2024A1515012602Macau Young Scholars Program AM2024027National Key Research and Development Program of China 2022YFD1801200National Natural Science Foundation of China 62202383National Natural Science Foundation of China 62433016Science and Technology Development Fund 0002/2024/RIA1State Key Laboratory for Animal Disease Control and Prevention Foundation SKLADCPKFKT202407
6 · The paper itself

Abstract

Cancer driver genes play a pivotal role in understanding cancer development, progression, and therapeutic discovery. The plenty of accumulation of multi-omics data and biological networks provides a data foundation for graph neural network (GNN) frameworks. However, most existing methods directly concatenate multi-omics data as features, which may lead to limited performance. To address this limitation, we propose deepCDG, a deep graph convolutional network (GCN)-based multi-omics integration model for cancer driver gene identification. The model first employs shared-parameter GCN encoders to extract representations from three omics perspectives, followed by feature integration through an attention layer, and finally utilizes a residual-connected GCN predictor for cancer driver gene identification. Additionally, deepCDG employs GNNExplainer for cancer driver gene module identification. Experimental results demonstrate the effective predictive performance, model robustness, and computational efficiency of deepCDG. Additionally, biological interpretability analysis further validates the reliability of the identification of cancer driver genes of our framework, and the identified gene modules provide profound insights into complex inter-gene relationships and interactions. We believe our method offers enhanced applicability for cancer driver gene identification and could be extended to other biological research fields in future studies.

Indexed as

Computational BiologyGene Regulatory NetworksGenomicsNeoplasmsNeural Networks, ComputerHumansMultiomicscancer driver genesgene modulesgraph convolutional networksmulti-omics data

Identifiers

PMID40716043
PMCPMC12296362

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.